Meetings: National Cancer Institute,

[Federal Register: March 20, 2000 (Volume 65, Number 54)]

[Notices]

[Page 14989-14990]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr20mr00-99]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the Board of Scientific Counselors, National Cancer Institute.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), Title 5 U.S.C., as amended. The discussions could reveal information of a personal nature where disclosure would constitute a clearly unwarranted invasion of personal privacy and the premature disclosure of discussions related to personnel and programmatic issues would be likely to significantly frustrate the subsequent implementation of recommendations.

Name of Committee: Board of Scientific Counselors, National Cancer Institute, Subcommittee A--Clincal Sciences and Epidemiology.

Date: March 22-23, 2000.

Closed: March 22, 2000, 7 pm to 10:15 pm.

Agenda: Chairman's Remarks and Discussion of personnel and programmatic issues; Review and evaluation of individual Principal Investigators.

Place: Residence Inn by Marriott, Montgomery II, 7335 Wisconsin Ave., Bethesda, MD 20814.

Name of Committee: Board of Scientific Counselors, National Cancer Institute, Subcommittee B--Basic Sciences.

Date: March 22-23, 2000.

Closed: March 22, 2000, 7 pm to 9:50 pm.

Agenda: Chairman's Remarks and Discussion of personnel and programmatic issues; Site visit Reports; Review and evaluation of individual Principal Investigators.

Place: Holiday Inn-Washington/Chevy Chase, Somerset Room, 5520 Wisconsin Ave., Chevy Chase, MD 20815.

Open: March 23, 2000, 8 am to 9:30 am.

Agenda: Joint Session with Board of Scientific Counselors, National Cancer Institute, Subcommittee A--Clinical Sciences and Epidemiology and the National Cancer Institute, Board of Scientific Advisors Report of the Director, NCI.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Closed: March 23, 2000, 9:30 am to 10:30 am. Joint Meeting of the Board of Scientific Counselors, National Cancer Institute, Subcommittee A--Clincal Sciences and Epidemiology and Subcommittee B--Basic Sciences.

Agenda: To review and evaluate personal qualifications and performance and competence of individual investigators.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.

Name of Committee: Board of Scientific Counselors, National Cancer Institute, Subcommittee A-- Clinical Sciences and Epidemiology.

Closed: March 23, 2000, 10:30 am to 4 pm.

Agenda: To review and evaluate personal qualifications and performance and competence of individual investigators.

Place: Hyatt Regency Bethesda, Fellini's One Bethesda Metro Center, Bethesda, MD 20814.

Open: March 23, 2000, 4 pm to 4:45 pm.

Agenda: Concept Review: Human papillomavirus type 16 vaccine trial in Costa Rica.

Place: Hyatt Regency Bethesda, Fellini's, One Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Abby Sandler, Executive Secretary, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 7019, Bethesda, MD 20892, (301) 496-7628.

Name of Committee: Board of Scientific Counselors, National Cancer Institute, Subcommittee B--Basic Sciences.

Closed: March 23, 2000, 10:30 am to 5:30 pm.

[[Page 14990]]

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Rooms 6 and 7, Bethesda, MD 20892.

Contact Person: Florence E. Farber, Executive Secretary, Institute Review Office; Office of the Director, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 7017, Bethesda, MD 20892, (301) 496-7628.

This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the intramural research review cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: March 9, 2000. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-6769Filed3-17-00; 8:45 am]

BILLING CODE 4140-01-M